MR‐guided percutaneous ethanol ablation of hepatocellular carcinomas before liver transplantation

References

• Bruix J., Sherman M., Llovet J. M., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona‐2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421–30
   PubMed Web of Science ®Google Scholar
• Majno P. E., Adam R., Bismuth H., et al. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. Ann Surg 1997; 226: 688–701, discussion 701
   PubMed Web of Science ®Google Scholar
• Troisi R., Defreyne L., Hesse U. J., Praet M., et al. Multimodal treatment for hepatocellular carcinoma on cirrhosis: the role of chemoembolization and alcoholization before liver transplantation. Clin Transplant 1998; 12: 313–9
   Google Scholar
• Poon R. T., Fan S. T., Tsang F. H., Wong J. Locoregional therapies for hepatocellular carcinoma: a critical review from the surgeon's perspective. Ann Surg 2002; 235: 466–86
   PubMed Web of Science ®Google Scholar
• Lu D. S., Sinha S., Lucas J., Farahani K., et al. MR‐guided percutaneous ethanol ablation of liver tissue in a.2‐T open MR system: preliminary study in porcine model. J Magn Reson Imaging 1997; 7: 303–8
   Google Scholar
• Lu D. S., Yu N. C., Raman S. S., et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 2005; 41: 1130–7
   PubMed Web of Science ®Google Scholar
• Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693–9
   PubMed Web of Science ®Google Scholar
• Kettenbach J., Kostler W., Rucklinger E., et al. Percutaneous saline‐enhanced radiofrequency ablation of unresectable hepatic tumors: initial experience in 26 patients. AJR Am J Roentgenol 2003; 180: 1537–45
   PubMed Web of Science ®Google Scholar
• Kim Y. J., Raman S. S., Yu N. C., Lu D. S. MR‐guided percutaneous ethanol injection for hepatocellular carcinoma in a 0.2T open MR system. J Magn Reson Imaging 2005; 22: 566–71
   PubMed Web of Science ®Google Scholar
• Braga H. J., Choti M. A., Lee V. S., Paulson E. K., et al. Liver lesions: manganese‐enhanced MR and dual‐phase helical CT for preoperative detection and characterization comparison with receiver operating characteristic analysis. Radiology 2002; 223: 525–31
   PubMed Web of Science ®Google Scholar
• Gaiani S., Celli N., Cecilioni L., Piscaglia F., et al. Review article: percutaneous treatment of hepatocellular carcinoma. Aliment Pharmacol Ther 2003; 17(Suppl 2)103–10
   PubMed Web of Science ®Google Scholar
• Livraghi T., Bolondi L., Lazzaroni S., et al. Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients. Cancer 1992; 69: 925–9
   PubMed Web of Science ®Google Scholar
• Livraghi T., Giorgio A., Marin G., et al. Hepatocellular carcinoma and cirrhosis in 746 patients: long‐term results of percutaneous ethanol injection. Radiology 1995; 197: 101–8
   PubMed Web of Science ®Google Scholar
• Baron R. L., Oliver J. H., 3rd., Dodd G. D., 3rd., Nalesnik M., et al. Hepatocellular carcinoma: evaluation with biphasic, contrast‐enhanced, helical CT. Radiology 1996; 199: 505–11
   PubMedGoogle Scholar
• Becker C. D., Grossholz M., Mentha G., et al. Ablation of hepatocellular carcinoma by percutaneous ethanol injection: imaging findings. Cardiovasc Intervent Radiol 1997; 20: 204–10
   Google Scholar
• Shibata T., Iimuro Y., Yamamoto Y., et al. CT‐guided transthoracic percutaneous ethanol injection for hepatocellular carcinoma not detectable with US. Radiology 2002; 223: 115–20
   PubMed Web of Science ®Google Scholar
• Lewin J. S., Connell C. F., Duerk J. L., et al. Interactive MRI‐guided radiofrequency interstitial thermal ablation of abdominal tumors: clinical trial for evaluation of safety and feasibility. J Magn Reson Imaging 1998; 8: 40–7
   PubMed Web of Science ®Google Scholar
• Lu D. S., Lee H., Farahani K., Sinha S., et al. Biopsy of hepatic dome lesions: semi‐real‐time coronal MR guidance technique. AJR Am J Roentgenol 1997; 168: 737–9
   Google Scholar
• Kettenbach J., Kacher D. F., Kanan A. R., et al. Intraoperative and interventional MRI: recommendations for a safe environment. Minim Invasive Ther Allied Technol 2006; 15: 53–64
   PubMed Web of Science ®Google Scholar
• Zangos S., Kiefl D., Eichler K., et al. [MR‐guided biopsies of undetermined liver lesions: technique and results]. Rofo 2003; 175: 688–94
   Google Scholar
• Lencioni R., Paolicchi A., Moretti M., et al. Combined transcatheter arterial chemoembolization and percutaneous ethanol injection for the treatment of large hepatocellular carcinoma: local therapeutic effect and long‐term survival rate. Eur Radiol 1998; 8: 439–44
   Google Scholar
• Livraghi T., Goldberg S. N., Lazzaroni S., Meloni F., et al. Small hepatocellular carcinoma: treatment with radio‐frequency ablation versus ethanol injection. Radiology 1999; 210: 655–61
   PubMed Web of Science ®Google Scholar
• Meloni F., Lazzaroni S., Livraghi T. Percutaneous ethanol injection: single session treatment. Eur J Ultrasound 2001; 13: 107–15
   Google Scholar
• Befeler A. S., Di Bisceglie A. M. Hepatocellular carcinoma: diagnosis and treatment. Gastroenterology 2002; 122: 1609–19
   PubMed Web of Science ®Google Scholar
• Livraghi T. Radiofrequency ablation, PEIT, and TACE for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2003; 10: 67–76
   PubMedGoogle Scholar
• Fontana R. J., Hamidullah H., Nghiem H., et al. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transpl 2002; 8: 1165–74
   PubMed Web of Science ®Google Scholar
• Rhim H., Goldberg S. N., Dodd G. D., 3rd., et al. Essential techniques for successful radio‐frequency thermal ablation of malignant hepatic tumors. Radiographics 2001; 21 Spec No: S17–35, discussion S36–19
   Google Scholar
• Buscarini L., Di Stasi M., Buscarini E., et al. Clinical presentation, diagnostic work‐up and therapeutic choices in two consecutive series of patients with hepatocellular carcinoma. Oncology 1996; 53: 204–9
   Google Scholar
• Bruix J., Llovet J. M. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology 2002; 35: 519–24
   PubMed Web of Science ®Google Scholar
• Llovet J. M., Fuster J., Bruix J. Intention‐to‐treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 1999; 30: 1434–40
   PubMed Web of Science ®Google Scholar
• Yao F. Y., Ferrell L., Bass N. M., et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394–1403
   PubMed Web of Science ®Google Scholar
• Stippel D. L., Kasper H. U., Schleimer K., Benz C., et al. Underestimation of nodules while staging hepatocellular carcinoma prior to neoadjuvant treatment on waiting list for transplantation. Transplant Proc 2003; 35: 1423–4
   Google Scholar
• Graziadei I. W., Sandmueller H., Waldenberger P., et al. Chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl 2003; 9: 557–63
   PubMed Web of Science ®Google Scholar
• Burdio F., Guemes A., Burdio J. M., et al. Hepatic lesion ablation with bipolar saline‐enhanced radiofrequency in the audible spectrum. Acad Radiol 1999; 6: 680–6
   PubMed Web of Science ®Google Scholar
• Llovet J. M., Mas X., Aponte J. J., et al. Cost effectiveness of adjuvant therapy for hepatocellular carcinoma during the waiting list for liver transplantation. Gut 2002; 50: 123–8
   PubMed Web of Science ®Google Scholar
• Rossi S., Buscarini E., Garbagnati F., et al. Percutaneous treatment of small hepatic tumors by an expandable RF needle electrode. AJR Am J Roentgenol 1998; 170: 1015–22
   PubMed Web of Science ®Google Scholar
• Livraghi T., Goldberg S. N., Lazzaroni S., et al. Hepatocellular carcinoma: radio‐frequency ablation of medium and large lesions. Radiology 2000; 214: 761–8
   PubMed Web of Science ®Google Scholar
• Nahum Goldberg S., Dupuy D. E. Image‐guided radiofrequency tumor ablation: challenges and opportunities–art I. J Vasc Interv Radiol 2001; 12: 1021–32
   PubMed Web of Science ®Google Scholar
• Dupuy D. E., Goldberg S. N. Image‐guided radiofrequency tumor ablation: challenges and opportunities–art II. J Vasc Interv Radiol 2001; 12: 1135–48
   PubMed Web of Science ®Google Scholar
• Hansler J., Frieser M., Schaber S., et al. Radiofrequency ablation of hepatocellular carcinoma with a saline solution perfusion device: a pilot study. J Vasc Interv Radiol 2003; 14: 575–80
   Google Scholar
• Meloni M. F., Goldberg S. N., Moser V., Piazza G., et al. Colonic perforation and abscess following radiofrequency ablation treatment of hepatoma. Eur J Ultrasound 2002; 15: 73–6
   PubMedGoogle Scholar